- Home
- RAPT vs CULP Comparison
RAPT vs CULP Comparison
Compare RAPT & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- CULP
- Stock Information
- Founded
- RAPT 2015
- CULP 1972
- Country
- RAPT United States
- CULP United States
- Employees
- RAPT N/A
- CULP N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- CULP Textiles
- Sector
- RAPT Health Care
- CULP Consumer Discretionary
- Exchange
- RAPT Nasdaq
- CULP Nasdaq
- Market Cap
- RAPT 59.1M
- CULP 66.1M
- IPO Year
- RAPT 2019
- CULP N/A
- Fundamental
- Price
- RAPT $1.25
- CULP $5.16
- Analyst Decision
- RAPT Hold
- CULP
- Analyst Count
- RAPT 10
- CULP 0
- Target Price
- RAPT $6.00
- CULP N/A
- AVG Volume (30 Days)
- RAPT 627.1K
- CULP 11.4K
- Earning Date
- RAPT 03-06-2025
- CULP 03-05-2025
- Dividend Yield
- RAPT N/A
- CULP N/A
- EPS Growth
- RAPT N/A
- CULP N/A
- EPS
- RAPT N/A
- CULP N/A
- Revenue
- RAPT N/A
- CULP $222,157,000.00
- Revenue This Year
- RAPT N/A
- CULP $1.94
- Revenue Next Year
- RAPT N/A
- CULP $10.13
- P/E Ratio
- RAPT N/A
- CULP N/A
- Revenue Growth
- RAPT N/A
- CULP N/A
- 52 Week Low
- RAPT $0.79
- CULP $4.25
- 52 Week High
- RAPT $10.05
- CULP $6.85
- Technical
- Relative Strength Index (RSI)
- RAPT 53.72
- CULP 41.35
- Support Level
- RAPT $1.10
- CULP $5.19
- Resistance Level
- RAPT $1.30
- CULP $5.49
- Average True Range (ATR)
- RAPT 0.09
- CULP 0.23
- MACD
- RAPT 0.02
- CULP -0.01
- Stochastic Oscillator
- RAPT 72.00
- CULP 23.26
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About CULP Culp Inc.
Culp Inc manufactures, sources, and markets mattress fabrics and sewn covers used for covering mattresses and box springs and upholstery fabrics including cut and sewn kits used in the production of upholstered furniture. The company has two operating segments Mattress fabrics which generates maximum revenue, and Upholstery fabrics. The mattress fabrics segment, also known as Culp Home Fashions, manufactures and markets mattress fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment markets fabrics for residential, commercial, and hospitality furniture and also provides window treatment products and installation services for its customers in the hospitality and commercial industries. Geographically, it derives key revenue from the United States of America.